Sandu Pharmaceuticals Share Price
38.26-0.86 (-2.20%)
-20.31% past 1 Year
Sandu Pharmaceuticals Limited was incorporated in India on November 15, 1985. The company is mainly engaged in the business of manufacturing and trading of Ayurvedic medicines under the brand name
Corporate filings & documents
Announcements
Newspaper Publication opening of special window for re-lodgement of transfer request for physical shares
2 hours agoNewspaper Advertisement intimating shareholders about Notice of Annual General Meeting and Evoting
2 weeks agoNewspaper Advertisement intimating shareholders about Notice of Annual General Meeting and Evoting
2 weeks agoLetters to shareholders on annual report weblink whose email ids are not registered with the company/RTA
2 weeks agoLetters to shareholders on annual report weblink whose email ids are not registered with the company/RTA
2 weeks ago41st Annual Report of Sandu Pharmaceuticals Limited
2 weeks ago41st Annual Report of Sandu Pharmaceuticals Limited
2 weeks agoIntimation about Annual General Meeting
2 weeks agoIntimation about Annual General Meeting
2 weeks agoNewspaper Advertisement Pre despatch of Annual Report intimation to Shareholders
3 weeks agoNewspaper Advertisement Pre despatch of Annual Report intimation to Shareholders
3 weeks agoNewspaper Publication Unaudited Financials for Q ended 30th June 2026
3 weeks agoNewspaper Publication Unaudited Financials for Q ended 30th June 2026
3 weeks agoapproval of material related party transactions subject to approval of shareholder
3 weeks agoapproval of material related party transactions subject to approval of shareholder
3 weeks agostatement of deviation and utlisation of funds for q ended 30.06.2026
3 weeks agostatement of deviation and utlisation of funds for q ended 30.06.2026
3 weeks agoAppointment of M/s Dave & Dave Chartered Accountant as statutory auditor subject to approval of the shareholder
3 weeks agoAppointment of M/s Dave & Dave Chartered Accountant as statutory auditor subject to approval of the shareholder
3 weeks agoIntimation about the date of the annual General Meeting
3 weeks agoIntimation about the date of the annual General Meeting
3 weeks agoIntimation about the Record date
3 weeks agoIntimation about the Record date
3 weeks agoIntimation about Book closure for AGM
3 weeks agoIntimation about Book closure for AGM
3 weeks agoOutcome and results of the Board Meeting dated 11.08.2026
3 weeks agoOutcome and results of the Board Meeting dated 11.08.2026
3 weeks agoUnaudited Financials For ended 30.06.2026
3 weeks agoUnaudited Financials For ended 30.06.2026
3 weeks agoOutcome of the Board Meeting 11.08.2026
3 weeks agoOutcome of the Board Meeting 11.08.2026
3 weeks agoOutcome of the Board Meeting
3 weeks agoOutcome of the Board Meeting
3 weeks agoSandu Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 inter alia to consider and approve 1.To consider and approve the Standalone Unaudited Financial Results of the Company for the quarter ended 30th June 2026. 2.To consider any other matter with the permission of the Chair
1 month agoSandu Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 inter alia to consider and approve 1.To consider and approve the Standalone Unaudited Financial Results of the Company for the quarter ended 30th June 2026. 2.To consider any other matter with the permission of the Chair
1 month agoReconstitution of Committees of Board-Audit/Nomination/Stakeholders
1 month agoReconstitution of Committees of Board-Audit/Nomination/Stakeholders
1 month ago1.Appointment of Dr Neeti Madan Kapre (DIN:06801264) as additional Non Executive Independent Director of the Company2.Redesignation of Shri Balram Viswanathan (DIN: 10245195) as Chairman and Managing Director of the Company
1 month ago1.Appointment of Dr Neeti Madan Kapre (DIN:06801264) as additional Non Executive Independent Director of the Company2.Redesignation of Shri Balram Viswanathan (DIN: 10245195) as Chairman and Managing Director of the Company
1 month agoOutcome of the Board Meeting dated 11.07.2026
1 month agoOutcome of the Board Meeting dated 11.07.2026
1 month agonewspaper publication-opening of special window for relodgment of special window for transfer of shares and second 100 days campaign saksham niveshak
1 month agonewspaper publication-opening of special window for relodgment of special window for transfer of shares and second 100 days campaign saksham niveshak
1 month agoCertificate under Regulation 74(5) of SEBI(DP) Regulation
1 month agoCertificate under Regulation 74(5) of SEBI(DP) Regulation
1 month agoSandu Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/07/2026 inter alia to consider and approve 1. To place on record the demise of Shri Umesh B. Sandu(DIN:01132141) Managing Director of the Company on 19th June 2026 and to record the Boards appreciation for his invaluable contribution to the Company.2. To consider and approve the appointment of a Managing Director of the Company pursuant to the demise of the erstwhile Managing Director Late Shri Umesh B. Sandu subject to the approval of the shareholders of the Company and such other statutory and regulatory approvals as may be required.3. To consider and approve the reconstitution of the Committees of the Board.4. To consider and approve the appointment of an Additional Director in the capacity of an Independent Director (Non-Executive) on the Board of the Company subject to the approval of the shareholders of the Company and such other statutory and regulatory approvals if any as may be required.
2 months agoSandu Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/07/2026 inter alia to consider and approve 1. To place on record the demise of Shri Umesh B. Sandu(DIN:01132141) Managing Director of the Company on 19th June 2026 and to record the Boards appreciation for his invaluable contribution to the Company.2. To consider and approve the appointment of a Managing Director of the Company pursuant to the demise of the erstwhile Managing Director Late Shri Umesh B. Sandu subject to the approval of the shareholders of the Company and such other statutory and regulatory approvals as may be required.3. To consider and approve the reconstitution of the Committees of the Board.4. To consider and approve the appointment of an Additional Director in the capacity of an Independent Director (Non-Executive) on the Board of the Company subject to the approval of the shareholders of the Company and such other statutory and regulatory approvals if any as may be required.
2 months agointimation about closure of trading window for q ended 30th June 2026
2 months agointimation about closure of trading window for q ended 30th June 2026
2 months agodemise of Shri Umesh Sandu Managing Director (DIN:01132141) revised disclosure
2 months agoAnnual reports
Concalls & investor presentations
No presentations found
Corporate Actions
Date
Type
Details
2026-09-04
Dividend
1.0
2025-09-18
Dividend
0.8
2024-09-19
Dividend
0.8
2023-09-18
Dividend
0.75
Company details
Registered office
Plot No 25, 26, 29 & 30 Pilerne Industrial Estate Saligao, Marra Bardez Goa PIN: 403511 Tel No: 0832-2407474 / 6715000 Fax No: 0832-2407008 Email: [email protected] Internet: www.sandu.in
Registrars
C 101, 247 Park, L B S Marg, Vikhroli (West), Mumbai 400 083.Tel: 2851 5606/ 2851 5644 Fax: 2851 2885E-mail: [email protected] C 101, 247 Park L B S Marg Vikhroli (West) PIN: Tel No: 2851 5606/ 2851 5644 Fax No: 2851 2885 Email: [email protected] Internet: https://in.mpms.mufg.com/
Management
Pratika Mhambray, Company Secretary & Compliance Officer
Balram Viswanathan, Chairman & Managing Director
Balram Viswanathan, Chairman & Managing Director
Ajit R Kantak, Non Executive Independent Director
Vijay Kottapalli, Non Executive Independent Director
Shashank B Sandu, Non Independent & Non Executive Director
Jayshree Sandu, Non Independent & Non Executive Director
Details
BSE 524703
NSE NULL
ISIN INE751D01014